ACLARIS THERAPEUTICS INC (ACRS:NASDAQ)

$4.34 -0.02 (-0.4587%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 68

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ACLARIS THERAPEUTICS INC (ACRS:NASDAQ) News Sources

Aclaris Therapeutics Announces Positive Full Top Line First-in-Human Results from Phase 1a Healthy Volunteer Clinical Trial of ATI-052, a Novel Potential First-in-Class Anti-TSLP/IL-4Rα Bispecific Antibody, and Announces Lichen Planus as Lead Indication for ATI-2138, an Oral ITK/JAK3 Inhibitor

28-04-2026

yahoo.com

Aclaris Therapeutics Updates ATI-052 Phase 1 Data, Picks ATI-2138 for Phase 2b in Lichen Planus

28-04-2026

marketbeat.com

Companies Like Aclaris Therapeutics (NASDAQ:ACRS) Are In A Position To Invest In Growth

04-05-2026

yahoo.com

Rigel Pharmaceuticals (RIGL) Lags Q1 Earnings and Revenue Estimates

05-05-2026

yahoo.com

Aclaris Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate and Clinical Update

07-05-2026

yahoo.com

Aclaris Therapeutics (ACRS) Reports Q1 Loss, Beats Revenue Estimates

07-05-2026

yahoo.com

Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference

08-05-2026

yahoo.com

Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

28-05-2026

yahoo.com

Aclaris Therapeutics Maps Busy Pipeline Calendar, Plans Phase 2 Asthma Trial for ATI-052

04-06-2026

marketbeat.com

Aclaris Therapeutics, Inc. (ACRS): A Top Penny Stock in Investors Portfolio That Stifel is Bullish On

07-06-2026

yahoo.com

ACLARIS THERAPEUTICS INC (ACRS:NASDAQ) Sentiment Trend

0 25 50 75 100 77 83 88 3 70 3 88 90 90 92 28-04-2026 04-05-2026 05-05-2026 07-05-2026 08-05-2026 28-05-2026 04-06-2026 07-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ACLARIS THERAPEUTICS INC (ACRS:NASDAQ) FAQs

toggle

What is the current price of ACLARIS THERAPEUTICS INC (ACRS:NASDAQ)?

The current price of ACLARIS THERAPEUTICS INC (ACRS:NASDAQ) is $4.34.


toggle

ACLARIS THERAPEUTICS INC (ACRS:NASDAQ) absolute price change since previous trading day?

The absolute price change of ACLARIS THERAPEUTICS INC (ACRS:NASDAQ) since the previous trading day is $-0.02.


toggle

ACLARIS THERAPEUTICS INC (ACRS:NASDAQ) percentage price change since previous trading day?

The percentage price change of ACLARIS THERAPEUTICS INC (ACRS:NASDAQ) since the previous trading day is -0.4587%.


toggle

What is the most recent average sentiment score for ACLARIS THERAPEUTICS INC (ACRS:NASDAQ)?

The most recent average sentiment score for ACLARIS THERAPEUTICS INC (ACRS:NASDAQ) is 68 out of 100.


toggle

What is the most recent average sentiment for ACLARIS THERAPEUTICS INC (ACRS:NASDAQ)?

The most recent sentiment for ACLARIS THERAPEUTICS INC (ACRS:NASDAQ) is .


SEC-8K** Filing Available For ACLARIS THERAPEUTICS INC (ACRS:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.